Duke Street Bio Ltd funding
Duke Street Bio Ltd, a biotechnology company based in London, United Kingdom, filed a Form D with the SEC on June 11, 2026 and reported $4.1M raised.
Amount raised$4.1M
Offering size$4.1M
Filed with the SECJune 11, 2026
First saleMay 15, 2026
IndustryBiotechnology
SecuritiesEquity
LocationLondon, United Kingdom
FoundedMore than 5 years ago
Entity typeOther
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 11
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology